http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. Following several years of study, investigators have found more evidence that viral therapy to treat solid tumors can be enhanced by blocking the body's natural immune response. http://medicalxpress.com/news/2013-03-evidence-blocking-immune-response-viral.html Cancer Wed, 13 Mar 2013 12:47:16 EST news282397623 (HealthDay)—Lactate dehydrogenase (LDH) levels may be predictive of success in treating chemotherapy-naive patients with advanced melanoma with a combination of elesclomol plus paclitaxel, according to research published online Feb. 11 in the Journal of Clinical Oncology. http://medicalxpress.com/news/2013-02-adding-elesclomol-paclitaxel-advanced-melanoma.html Cancer Fri, 22 Feb 2013 17:00:01 EST news280765883 Although a large majority of head and neck cancers have a deregulation of the PI3K/AKT/mTOR pathway, data recently published in Cancer Research, a journal of the American Association for Cancer Research, indicated that deregulation of this pathway does not necessarily signify that the tumor is dependent on it for survival and progression. http://medicalxpress.com/news/2013-01-common-genetic-neck-cancers-key.html Cancer Tue, 29 Jan 2013 13:00:01 EST news278676552 The American Society of Clinical Oncology (ASCO) has just released its annual report on the top cancer advances of the year. Clinical Cancer Advances 2012: ASCO's Annual Report on Progress Against Cancer, highlights major achievements in precision medicine, cancer screening and overcoming treatment resistance. http://medicalxpress.com/news/2012-12-american-society-clinical-oncology-issues.html Cancer Mon, 03 Dec 2012 16:00:12 EST news273757673 There are plenty of effective anticancer agents around. The problem is that, very often, they cannot gain access to all the cells in solid tumors. A new gene delivery vehicle may provide a way of making tracks to the heart of the target. http://medicalxpress.com/news/2012-11-cancer-therapy-nanokey-tumors.html Cancer Wed, 14 Nov 2012 11:04:22 EST news272113452 New understanding of how drugs called PARP inhibitors, which have already shown promise for the treatment of women with familial breast and ovarian cancers linked to BRCA mutations, exert their anticancer effects has led to the identification of ways in which the patient population that might benefit from PARP inhibitors could be expanded. http://medicalxpress.com/news/2012-11-mechanism-action-parp-inhibitors.html Cancer Fri, 09 Nov 2012 11:29:43 EST news271682973 Advances in chemotherapy have dramatically improved the outlook for many cancer patients, but the side effects of this treatment are daunting. A new generation of chemotherapy drugs with fewer side effects is the goal of Edward J. Merino, assistant professor of chemistry at the University of Cincinnati. http://medicalxpress.com/news/2012-03-metabolic-pollution-anticancer-treatments.html Cancer Mon, 26 Mar 2012 08:20:01 EST news251967762 A team of German and Italian EU-funded scientists has designed peptides that can target the protein-protein interface of an enzyme that plays a key part in the DNA synthesis crucial for cancer growth. http://medicalxpress.com/news/2011-08-peptides-ovarian-cancer.html Cancer Mon, 08 Aug 2011 10:22:28 EST news232017724 Today's anticancer drugs often work wonders against malignancies, but sometimes tumors become resistant to the effects of such drugs, and treatment fails. Medical researchers would like to find ways of counteracting such resistance, but first they must understand why and how it happens. New findings by Fox Chase Cancer Center researchers identify one protein, Abcc10 (also known as Mrp7), as being intimately involved in resistance to certain drugs used to treat breast, ovarian, lung, and other cancers. The results suggest that blunting the activity of Abcc10 might help counter resistance and extend the effectiveness of these anticancer drugs. http://medicalxpress.com/news/2011-05-abcc10-effective-effectiveness-anticancer-drugs.html Cancer Mon, 16 May 2011 09:58:57 EST news224758722